Bardoxolone methyl (BM) prevented high-fat (HF) diet-induced obesity.
BM prevented HF diet-induced hypothalamic leptin resistance.
BM prevented HF diet-induced hypothalamic inflammation.
BM prevented impairments to hypothalamic leptin signalling induced by a HF diet.